Angiotensin-converting enzyme inhibitor and angiotensin AT1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity. Pharmacological

Faculty of Medicine

Assiut University

Angiotensin-converting enzyme inhibitor and angiotensin AT1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity. Pharmacological

Research Authors
Ibrahim M.A., Ashour O.M., Ibrahim Y.F. El-Bitar H.I
Research Department
Department of Pharmacology
Research Journal
Research, 60, 373-381.
Research Member
Hussein Ismail Ahmed El-Bitar
Research Rank
1
Research Year
2009